BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2934864)

  • 1. Action of crotalase, an enzyme with thrombin-like and kallikrein-like specificities, on tripeptide nitroanilide derivatives.
    Simmons G; Bundalian M; Theodor I; Martinoli J; Pirkle H
    Thromb Res; 1985 Nov; 40(4):555-61. PubMed ID: 2934864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active-site mapping of bovine and human blood coagulation serine proteases using synthetic peptide 4-nitroanilide and thio ester substrates.
    Cho K; Tanaka T; Cook RR; Kisiel W; Fujikawa K; Kurachi K; Powers JC
    Biochemistry; 1984 Feb; 23(4):644-50. PubMed ID: 6370301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New fluorogenic substrates for alpha-thrombin, factor Xa, kallikreins, and urokinase.
    Morita T; Kato H; Iwanaga S; Takada K; Kimura T
    J Biochem; 1977 Nov; 82(5):1495-8. PubMed ID: 591514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kallikrein-like activity of crotalase, a snake venom enzyme that clots fibrinogen.
    Markland FS; Kettner C; Schiffman S; Shaw E; Bajwa SS; Reddy KN; Kirakossian H; Patkos GB; Theodor I; Pirkle H
    Proc Natl Acad Sci U S A; 1982 Mar; 79(6):1688-92. PubMed ID: 7043462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic properties of tripeptide lysyl chloromethyl ketone and lysyl p-nitroanilide derivatives towards trypsin-like serine proteinases.
    Collen D; Lijnen HR; De Cock F; Durieux JP; Loffet A
    Biochim Biophys Acta; 1980 Sep; 615(1):158-66. PubMed ID: 6448639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The action of thrombin on peptide p-nitroanilide substrates: hydrolysis of Tos-Gly-Pro-Arg-pNA and D-Phe-Pip-Arg-pNA by human alpha and gamma and bovine alpha and beta-thrombins.
    Lottenberg R; Hall JA; Fenton JW; Jackson CM
    Thromb Res; 1982 Nov; 28(3):313-32. PubMed ID: 7179220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic studies of urokinase-catalysed hydrolysis of 5-oxo-L-prolylglycyl-L-arginine 4-nitroanilide.
    Ipsen HH; Christensen U
    Biochim Biophys Acta; 1980 Jun; 613(2):476-81. PubMed ID: 6449958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human alpha- and gamma-thrombin specificity with tripeptide p-nitroanalide substrates under physiologically relevant conditions.
    Witting JI; Miller TM; Fenton JW
    Thromb Res; 1987 May; 46(4):567-74. PubMed ID: 3617013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serine protease specificity for peptide chromogenic substrates.
    Mattler LE; Bang NU
    Thromb Haemost; 1977 Dec; 38(4):776-92. PubMed ID: 146272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the effect of serine protease inhibitors on activated contact factors. Application in amidolytic assays for factor XIIa, plasma kallikrein and factor XIa.
    Tans G; Janssen-Claessen T; Rosing J; Griffin JH
    Eur J Biochem; 1987 May; 164(3):637-42. PubMed ID: 3552674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New chromogenic substrates for thrombin with increased specificity.
    Kolde HJ; Eberle R; Heber H; Heimburger N
    Thromb Haemost; 1986 Oct; 56(2):155-9. PubMed ID: 2949389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic study of the effect of heparin on the amidase activity of trypsin, plasmin and urokinase.
    Yomtova VM; Stambolieva NA; Blagoev BM
    Thromb Haemost; 1983 Jun; 49(3):199-203. PubMed ID: 6224310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping the active sites of bovine thrombin, factor IXa, factor Xa, factor XIa, factor XIIa, plasma kallikrein, and trypsin with amino acid and peptide thioesters: development of new sensitive substrates.
    McRae BJ; Kurachi K; Heimark RL; Fujikawa K; Davie EW; Powers JC
    Biochemistry; 1981 Dec; 20(25):7196-206. PubMed ID: 6976185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin specificity with tripeptide chromogenic substrates: comparison of human and bovine thrombins with and without fibrinogen clotting activities.
    Sonder SA; Fenton JW
    Clin Chem; 1986 Jun; 32(6):934-7. PubMed ID: 3708816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic characterization of rat tissue kallikrein using N alpha-substituted arginine 4-nitroanilides and N alpha-benzoyl-L-arginine ethyl ester as substrates.
    Sousa MO; Rodrigues CV; Pena HB; Alvarenga MG; Machado-Coelho GL; Santoro MM; Juliano MA; Juliano L; Figueiredo AF
    Braz J Med Biol Res; 1996 Mar; 29(3):327-34. PubMed ID: 8736125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of substrates with 7-amino-3-trifluoromethylcoumarine (AFC) leaving group in the localization of protease activities in situ.
    Lojda Z
    Acta Histochem; 1996 Apr; 98(2):215-28. PubMed ID: 8739306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New synthetic substrate for kallikrein and its application.
    Fujii S; Hitomi Y; Kimura K; Ishii M; Kurumi M; Aoyama T
    Adv Exp Med Biol; 1986; 198 Pt A():299-308. PubMed ID: 2949541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [p-Nitroanilides of amino acids and peptides and fluorescence peptide with inner fluorescence quenching as substrates for cathepsins H, B, D and high molecular weight aspartic peptidase in the brain].
    Azarian AV; Agatian GL; Galoian AA
    Biokhimiia; 1987 Dec; 52(12):2033-7. PubMed ID: 3328984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and hydrolysis by arginyl-hydrolases of p-nitroanilide chromogenic substrates containing polyethylene glycol and D-gluconyl moieties.
    Juliano MA; Juliano L; Biondi L; Rocchi R
    Pept Res; 1991; 4(6):334-9. PubMed ID: 1821168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of chromogenic substrates for estimation of indicators of kallikrein-kinin and blood coagulation systems in blood plasma of patients with nephrotic syndrome].
    Baskova IP; Paskhina TS; Poliantseva LR; Iakubovskaia RI; Tiero A
    Vopr Med Khim; 1983; 29(5):96-9. PubMed ID: 6557709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.